# Bancfirst Corp: overview

BANF · Nasdaq · CIK 760498 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/banf.md) · [Financials](/companies/banf/financials.md) · [Filings](/companies/banf/filings.md) · [Insiders](/companies/banf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.75](/filings/0001193125-25-271672.md) | not reported | [1.66](/filings/0001193125-26-214181.md) | [1.85](/filings/0001193125-26-339980.md) | [1.85](/filings/0001193125-25-271672.md) | not reported | [1.85](/filings/0001193125-26-214181.md) | [1.96](/filings/0001193125-26-339980.md) |
| Free cash flow | $m | [72.4 d](/filings/0001193125-25-271672.md) | [2.0 d](/filings/0001193125-26-075954.md) | [65.6](/filings/0001193125-26-214181.md) | [64.4 d](/filings/0001193125-26-339980.md) | [63.7 d](/filings/0001193125-25-271672.md) | [43.2 d](/filings/0001193125-26-075954.md) | [65.1](/filings/0001193125-26-214181.md) | [73.3 d](/filings/0001193125-26-339980.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [5.03](/filings/0000950170-24-020908.md) | [5.77](/filings/0000950170-25-030159.md) | [6.34](/filings/0001193125-26-075954.md) | [6.44](/filings/0001193125-26-075954.md) | [7.11](/filings/0001193125-26-075954.md) |
| Free cash flow | $m | [177](/filings/0000950170-24-020908.md) | [206](/filings/0000950170-25-030159.md) | [211](/filings/0001193125-26-075954.md) | [225](/filings/0001193125-26-075954.md) | [237](/filings/0001193125-26-075954.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/banf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $356.1m | 3,203,944 |  | Added +112,335 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $265.7m | 2,390,554 |  | Reduced −199,535 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $163.2m | 1,462,013 |  | Added +136,522 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $159.8m | 1,437,508 |  | Reduced −105,941 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $108.1m | 973,155 |  | Reduced −111,285 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $101.9m | 917,104 |  | Added +47,559 |
| [BancFirst Trust & Investment Management](/funds/1914099.md) | 2026-06-30 | $100.6m | 895,974 |  | Added +23,984 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $64.2m | 577,235 |  | Added +44,101 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $31.3m | 281,297 |  | Added +11,359 |
| [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $29.7m | 267,137 |  | Reduced −1,640 |

## Recent filings

[All 1,199 filings](/companies/banf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 15:31 ET | [8-K](/filings/0001193125-26-429812.md) | 7.01 Regulation FD disclosure | 0001193125-26-429812 |
| 2026-10-22 | 21:35 ET | [8-K](/filings/0001193125-26-427999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-427999 |
| 2026-09-21 | 18:48 ET | [8-K](/filings/0001193125-26-396549.md) | 7.01 Regulation FD disclosure | 0001193125-26-396549 |
| 2026-08-07 | 18:24 ET | [10-Q](/filings/0001193125-26-339980.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339980 |
| 2026-07-23 | 20:38 ET | [8-K](/filings/0001193125-26-314223.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-314223 |
| 2026-06-10 | 21:04 ET | [8-K](/filings/0001193125-26-266024.md) | 7.01 Regulation FD disclosure | 0001193125-26-266024 |
| 2026-05-28 | 20:03 ET | [8-K](/filings/0001193125-26-245174.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0001193125-26-245174 |
| 2026-05-08 | 18:01 ET | [10-Q](/filings/0001193125-26-214181.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214181 |
| 2026-04-16 | 20:17 ET | [8-K](/filings/0001193125-26-159052.md) | 2.02 Results of operations | 0001193125-26-159052 |
| 2026-04-03 | 16:32 ET | [DEF 14A](/filings/0001193125-26-141692.md) | Proxy statement, period 2026-04-03 | 0001193125-26-141692 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-075954.md), filed Feb 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 760498
- Tickers: BANF, BANFP
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: OK
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.